The Biological Evaluation and Clinical Significance of Tubular and Post-renal Proteinuria.
Submitted to Leeds University for PhD degree April 1983.
書籍編著
1. Biochemical and Immunological Aspect of Bladder Cancer in man In: Bladder Cancer,pp54-79, Elsebai ed. CRC Press, Boca Raton Florida,1983
2. Tubular Proteinuria after Burn Injury. In: Advances in Non- invasive Nephrology, pp 187-190, Lubec & Compese eds. John Libbey, London 1985
3. Fast Protein Liquid Chromatography in the Seperation of Urinary Proteins. In: Advances in Non-invasive Nephrology, pp 219-223 Lubec & Compese eds, John Libbey, London, 1985
1. Yu H, Glashan R, Robinson MRG, Richards B, Fryzman A, Daponte D and Cooper EH. Changes in the Urine Protein Profile following Intravesical Doxorubicin. J Urol, 1982, 128, 128:271-275
2. Yu H, Cooper EH, Settle JAD and Meadows T. Urinary Protein Profile after Burn Injury. Burns, 1983, 9:339-349.
3. Yu H, Yanagisawa Y, Forbes MA, Cooper EH, Crockson RA and MacLemman ICM. Alpha-1-microglobulin, an Indicator Protein for Renal Tubular Function. J Clin Path 1983 36:253-259
4. Cooper EH, Yu H and Morgan DB. Tubulare Proteinurie. Laboratoriumslatter 1982 32:1-15
5. Marshall RJ, Yu H, Turner R and Cooper EH. Computer Analysis of Chromatographic Profile of Urine Proteins. In: Proceedings of Third International Symposium on HPLC of Proteins, Peptides and Polynucleotides. Nov 14-16 1983 Monte Carlo, Monaco
6. Cooper EH, Turner R, Yu H and Linblom. Fast Protein Liquid Chromatography in the Seperation of Urinary Proteins. In: Proceedings of International Conference on Non-invasive Diagnosis of Renal Diseases. Sept. 11-14 1983 Vienna
7. Yu H, Marshall R, Cooper EH and Settle JAD. Tubular Proteinuria after Burn Injury. idem.
8. Cooper EH, Yu H and Morgan DB. La proteinuria Tubulare. Ric Clin Lab 1983 13(suppl 2):31-43.
9. Bird HA, Yu H and Cooper EH. Renal Proximal Dysfunction in Patients with Rheumatic Diseases. Br Med J 1984 7:288(6423):1044-1045
10. Marshall RT, Turner R, Yu H and Cooper EH. Cluster Analysis of Chromatographic Profiles of Urine Proteins. J Chromatogr 1984;297:235-244
11. Cooper EH, Yu H and Glashan RW. Proteinuria after Intravesical Chemotherapy. In Proceedings of Conference on Chemotherapy of Bladder Cancer. May 1985 York
12. Sandberg T, Cooper EH, Lidin-Janson G and Yu H. Fever and Proximal Tubular Function in Acute Pyelonephritis. Nephron 1985:41:39-44
14. Zheng S. Yu H et al Estrogen Receptor Status of Breast Cancer and Prediction of Chemotherapy sensitivity. Presented at 15th International Congress of Chemotherapy July 19241987 Istanbul Turkey
43. Wang Min, Yu Hai, Zheng Shu et al. Inhibitory Effect of DFMO on the Growth of Transplanted Human Colon Cancer Nude Mice. Chin J Cancer Res 1991;3(4):18
66. Gan Yuebo, Zheng Shu, Yu Hai et al Localization of Type I and Type II procollagen mRNAs in Breast Scirrhous Carcinoma by in situ Hybridization. Clin J Cancer 1994;6(2):108
70. Yu Hai,Zhou Lun ,Zheng Shu et al. Evaluation of Reverse Passive hemag-glutination (RPHA) Fetal Occult Blood Test in Screening of Colorectal Neoplasia. Chin J Cancer Res 1994;6(4):74
88. Zhou Lun Yu Hai et al. Evaluation of fecal occult blood test with reverse passive hamagglutination for colorectal neopalsm screening China Natl J New Gastroenterol 1997; 3(1):38
92． Gong Yang, Wei Zheng, Hai Yu et al. Pathologic features of Initial Adenomas as predictors for Metachronous Adenomas of the Rectum. Journal of the National Cancer Institute, 1998, 90(21):1661
103．Wang Qingqing Yu Hai et al. Intratumoral IL-18 Gene Transfer Improves Therapeutic Efficacy Of Antibody-Targeted Superantigen In Established Murine Melanoma. Gene Therapy. 2001; 8:542-550 ( SCI IF 5.964)
104． Pan Jianping, Yu Hai et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunology Letter. 2001 April; 76: 153-161
110.Q Wang, H Yu et al. Vaccine with IL-18 gene modified, superantigen-coated tumor cells elicits potent antitumor immune response. J Cancer Res Clin Oncol. 2001; 127(12):718-726
111.Q Wang, H Yu et al. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer. J Mol Med 2002 Sep；80(9):585-94
120. Zhou Lun, Yu Hai and Chen Kun Relationship between microcystin in drinking water and colorectal cancer. Biomedical and Environmental Sciences 2002 15:166-171
121. Xiaohong Chen, Qun Tao, Hai Yu et al. Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity. Immunology Letters 84(2002)81-87
123. Zheng S, Chen K, Liu X, Ma X, Yu H et al. Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum 2003 Jan; 46(1):51-8
128. Wenxue Ma, Hai Yu, Qingqing Wang, et al. In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein. Cancer Immunology Immunotherapy 2004; 53(2):118-124
129. Changxin Huang, Hai Yu, Qingqing Wang et al Potant antitumor effect elicited by superantigen-linked tumor cells transduced with heat shock protein 70 gene. Cancer Science February 2004; 95(2):160-167
130. Wenxue Ma, Hai Yu, Qingqing Wang, Hongchuan Jin, Joyce Solheim and Vinod Labhasetwar. A novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor Immunity. J Clinical Immunology 2004; 24(3):293-301
136．Pingyong Yi, Hai Yu, Wenxue Ma and Qingqing Wang. Preparation of Murine B7.1-Glycosylphosphatidylinositol and Transmembrane-Anchored Staphylococcal Enterotoxin: A Dual-Anchored Tumor Cell Vaccine and its Antitumor Effect. Cancer 2005; 103(7):1519-1528（SCI IF4.434）
137．Changxin Huang, Hai Yu, Qingqing Wang, et al. A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy. Immunology Letters 101(2005) 71-80
139. Hongliang Huang, Guping Tang, Qingqing Wang, Da Li, Fenping Shen, Jun Zhou and Hai Yu* Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-b-cyclodextrin or (2-hydroxypropyl)-c-cyclodextrin Chem. Commun., 2006, 2382–2384
141. Li Da, Wang Qingqing, Tang Guping, Huang Hongliang, Shen Fenping, Li Jingzhong, Yu Hai. Receptou-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cell surface. Journal of Zhejiang University (Science B) 2006 7(11)：906-911
144. D. LI, G. P. TANG, J. Z. LI , Y. KONG, H. L. HUANG, L. J. MIN,J. ZHOU, F. P. SHEN, Q. Q. WANG, and H. YU: Dual-targeting non-viral vector based on polyethylenimine improves gene transfer efficiency. J. Biomater. Sci. Polymer Edn, Vol. 18, No. 5, pp. 545–560 (2007)
145. DA LI, HAI YU, HONGLIANG HUANG, FENPING SHEN,XIAOYUAN WU, JINGZHONG LI, JIANLI WANG, XUETAO CAO, QINGQING WANG,AND GUPING TANG: FGF Receptor-mediated Gene Delivery using Ligands Coupled to
146. Hongliang Huang, Hai Yu, Da Li, Yang Liu, Fenping Shen, Jun Zhou, Qingqing Wang and Guping Tang, A Novel Co-polymer Based on Hydroxypropyl α-Cyclodextrin Conjugated to Low Molecular Weight Polyethylenimine as an in Vitro Gene Delivery Vector Int. J. Mol. Sci. 2008, 9, 2278-2289;
論文摘要，譯著，綜述
1. Pearson T, Yu H et al. A course in preventive Cardiology in the People’s Republic of China. Presented in the American Heart Association 59th Scientific Session Sept. 1986
2. Yu Hai et al: The evaluation of RPHA Fecal Occult Blood Test in Screening for Colorectal Cancer. The First Symposium of Japan-China Congress for Colorectal Cancer November 14,1989
3. Zheng Shu , Yu Hai et al : Establishment of Screening Model for Colorectal Cancer Idem p7
4. Zheng S, Yu H et al. Screening for colorectal cancer with quantitative rish assessment and RPHA FOB test J of Cancer Res & Clin Oncol (supp) 1990, 116:131
5. Yu H, Wang M et al, Inhibition Effect of Polyamine Inhibitor DFMO on Human Colon Cancer Cell Line in vitro and in vivo. Idem 116:131
